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ABSTRACT 
 
Phytoestrogen is a group of compounds that can replace the estrogen function in the body. 
One of its roles was as anti-neuroinflammatory by inhibiting the microglia M1 polarity 
activation. Marsilea crenata Presl. is a plant that suspected to contain phytoestrogens. The 
aim of this research was to determine the metabolite profile of 96% ethanol extract of M. 
crenata using UPLC-QToF-MS/MS, and prediction the anti-neuroinflammatory activity of 
compounds with molecular docking. The 100 ppm of 96% ethanol extract in DCM and 
methanol were injected 5 µl each into the UPLC-QToF-MS/MS, and then analyzed by 
Masslynx 4.1 software to determine the compounds. The result of metabolite profiling shows 
a total 59 compounds in both DCM and methanol.  Molecular docking was done with 
Autodock 4.2.6. After being analyzed, there are 3 compounds that are predicted to have 
activities similar to 17β-estradiol, they are prochlorperazine, 12-Aminododecanoic acid, and 
1-methyl-2-[(4-methylpiperazin-1-yl)methyl]benzimidaol-5-amine hydrochloride. The 
results showed that the three compounds were predicted to be phytoestrogen compounds 
from M. crenata leaves, which have potential as anti-neuroinflammatory.  
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INTRODUCTION  
Marsilea. crenata Presl. is an 
aquatic plant that widely used as an 
ingredient for traditional food in Surabaya, 
Indonesia [1, 2]. Some of the research that 
had been done showed that 96% ethanol 
extract, n-hexane extract, and ethyl acetate 
extract of M. crenata leaves can inhibit 
osteoporosis in female mouse (mus 
musculus) with mechanism of bone 
formation improvement [3-6]. Other 
studies were also showed that n-hexane 
extract of M. crenata leaves can increase 
the alkaline phosphatase production in 
MC3T3-E1 preosteoblast cell 
differentiation process, which indirectly 
also play a role in bone formation 
improvement [3, 7]. 
This activity appears to be suspected 
because of the phytoestrogens content in 
M. crenata. Phytoestrogens are a group of 
compounds contained in plants which have 
estrogen-like structures or can replace the 
function of estrogen, either in association 
with estrogen receptors (ER-dependent) or 
not (ER-independent) [8-10]. The high 
phytoestrogen content in M. crenata raises 
allegations of its activity as a 
neuroprotective agent with anti-
neuroinflammatory mechanism. This 
mechanism can occur due to inhibition of 
microglia cells M1 polarity activation, 
where phytoestrogens bind to ER-β in 
microglia cells and prevent their activity to 
induce neuron apoptosis [11, 12]. 
Although it has great potential as a 
medicinal plants, the phytochemical 
properties of M. crenata has not been 
completely confirmed yet. This research 
was done to identify the metabolite profile 
of 96% ethanol extract of M. crenata using 
UPLC-QToF-MS/MS, which is a powerful 
technique used for metabolite profiling 
which has improved in performance of 
chromatographic resolution, speed and 
sensitivity analysis, saves time, also 
reduces solvent consumption [13].  
The in silico approach was used to 
develop new drugs from M. crenata leaves 
as anti-neuroinflammatory, as a 
preliminary test with the principle of 
tethering compounds from metabolite 
profiling analysis to a certain 
macromolecules such as ER-β, and 
determine the physicochemical properties 
of compounds against it [14]. Through the 
in silico approach, researchers can make 
the initial hypothesis and make simple 
predictions related to the potential activity 
of compounds, by correlating the structure 
and physicochemical properties using 
software analysis [15]. 
 
METHODS 
 
Material 
M. crenata were collected in 
Benowo, Surabaya, Indonesia at 
November 2017, and identified in UPT 
Materia Medica, Batu, Indonesia at 
December 2017 with specimen number 1a-
17b-18a-1. The leaves were prepared to get 
dry powder of M. crenata. 
All chemicals and reagent were 
analytical grade and used as received. 96% 
ethanol as solvent were purchased from 
Pharmacy Department, Faculty of Medical 
and Health Science, Maulana Malik 
Ibrahim State Islamic University. 
Dichloromethane, metanol, acetonitrile, 
and formic acid as solvent and mobile 
phase on UPLC-QToF-MS/MS were 
purchased from Central Forensic 
Laboratory Badan Reserse Kriminal 
Kepolisian Negara Republik Indonesia. 
 
Extraction 
Dry powder of M. crenata leaves 
were extracted with 96% ethanol using 
ultrasonic assisted extraction methods 
(Sonica 5300EP S3). This process was 
repeated, collecting all the supernatants, 
which were finally evaporated in a rotary 
evaporator (Heidolph) to get 96% ethanol 
extract. 
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Figure 1. Marsilea crenata Presl. 
 
 
Metabolite Profiling by UPLC-QToF-
MS/MS 
A simple, rapid, reliable and precise 
reversed phase UPLC-QToF-MS/MS 
method has been developed and validated 
according to the regulator guidelines. The 
96% ethanol extract preparation was done 
using solid phase extraction, 100 ppm of 
ethyl acetate extract in DCM and methanol 
then injected 5 µl each into the an 
ACQUITY UPLC® H-Class System 
(Waters, USA) coupled to an MS detector 
Xevo G2-S QToF (Waters, USA). Sample 
were separated on an ACQUITY BEH C18 
(1.7 µm 2.1×50 mm) with acetonitril + 0.05 
% formic acid and water + 0.05 % formic 
acid as mobile phase, with flowrate  0.2 
ml/min. The results of UPLC-MS analysis 
was processed using the Masslynx 4.1 
software, to obtain the data of peak and m/z 
spectra of each detected peak. The 
compound content can then be predicted 
using the chemspider website. 
 
Molecular Docking Simulation 
Receptor structure of ER-β used in 
this research was obtained from Protein 
Data Bank (http://www.rcsb.org) with 
code 3OLS [16]. Initial preparation was 
done to separate internal ligand (17β-
estradiol) from the protein using Biovia 
Discovery Studio Visualizer 2016. The 
secondary metabolite of M. crenata was 
prepared with SwissADME Web Tool [17] 
to predict its physicochemicals properties. 
The compounds that were predicted to 
penetrate the brain by using BOILED-Egg 
method [18] will be used for the next step 
as test compounds. Internal ligand and test 
compounds was prepared with Avogrado 
1.90.0 for energy optimization by using 
MMF94s method. Molecular docking was 
done using Pyrx 0.8 [19] with Autodock 
Vina [20] for molecular docking 
simulation. The receptor-ligand complexes 
from docking simulation were visualized 
using Biovia Discovery Studio Visualizer 
2016. 
 
RESULTS AND DISCUSSION  
 
Metabolite Profiling by UPLC-QToF-
MS/MS 
A total of 440 g dry powder of M. 
crenata leaves were extracted with 96% 
ethanol to produce 7 g extract. The 96% 
ethanol extract of M. crenata were 
analysed by UPLC-QToF-MS/MS to better 
interpret the diversity of available 
phytochemicals. Table 1 and Table 2 
summarise all the compounds 
characterized in 96% ethanol extract of M. 
crenata leaves, including retention times, 
% area, measured m/z, molecular formula, 
putative compounds, and its activity based 
on references. In total there were 42 peak 
of compounds identified in the methanol 
solvent, and 33 peak in the DCM solvent. 
The use of two types of solvent aimed to 
elute the 96% ethanol extract optimally. 
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From all the peaks, only 59 peaks can be 
identified, while the rest are unknown 
compounds. Unknown compounds may be 
identified as impure compounds which are 
still detected by the instrument, or they 
may be a new compounds, which is 
undetectable in chemspider database, 
especially unknown compounds with high 
concentrations. 
 
Molecular Docking Simulation 
The 59 compounds from the 
metabolite profiling analysis were 
screened by using SwissADME Web Tool 
[17] to predict the ability of compounds to 
penetrate BBB. The method used was the 
Boiled-EGG method [18], where the 
compounds that have topology polar 
surface area (TPSA) value  0-79 Å2 [21] 
and a logP value 0.4-6.0 possess the ability 
to penetrate the blood brain barrier (BBB). 
From the results of the analysis, there are 
19 compounds that are predicted to be able 
to penetrate the BBB. 
The compounds then analyzed with 
molecular docking using the PyRx 0.8 
program and AutoDock Vina [20] as a 
docking simulator. From the redocking 
test, the RMSD value was < 2 Å, so that the 
docking protocol can be used to docking 
the 19 compounds (Figure 2). From the 
results of analysis with Discovery Studio 
Visualizer 2016, it was found that there 
were 3 compounds predicted as ER-β 
agonists such as DCM10, MTL7, and 
MTL17 (Table 3), 6 compounds predicted 
as ER-β antagonist such as DCM4, 
DCM11, DCM14, DCM24, and MTL6 
(Table 4), and 10 compounds do not have 
activity in ER-β. To be able to act as an ER-
β agonist, the compound must interact with 
His475 amino acid residues and interact 
either with Glu305 or Arg346. The absence 
of interaction between the compound and 
His475 residue will cause the compound to 
act as an ER-β antagonist. 
 
 
 
Table 1 : Predicted compounds of 96% ethanol extract of M. crenata from Benowo District, 
Surabaya in methanol solvent 
No 
Rt 
(min) 
% Area 
Measured 
m/z 
Molecular 
Formula 
Proposed Metabolite Activity 
1 0.201 0.0228 124.9790 CH3NO6 Unknown - 
2 1.535 2.4313 235.1423 C10H21NO5 4-(3-Hydroxypropyl)-4-nitro-1,7-heptanediol - 
3 2.232 0.1510 179.1315 C11H21NO7 2[(tertButoxycarbonyl)amino-2-deoxy-D glucopyranose - 
4 2.518 1.5144 293.1479 C12H23NO7 
Methyl 6-deoxy-6-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-
β-D-glucopyranoside 
- 
5 3.799 1.4856 327.1314 C15H21NO7 Methyl (3,4,5-triethoxy-2-nitrophenyl)acetate - 
6 4.427 1.4055 187.0642 C5H15N3Cl2 4-Hydrazinopiperidine dihydrochloride - 
7 4.610 0.3629 162.0321 C9H6O3 3-Hydroxy-2H-chromen-2-one (3 hydroxycoumarin) 
Competitive inhibition of 
human recombinant  
DAAO [23]. 
8 4.896 0.1836 373.1375 C20H24N3SCl Prochlorperazine 
Analgesics [24], 
antiemetics [25] 
9 5.228 0.9215 359.0997 C13H18N5O5Cl 
Ethyl 4-[3-(4-chloro-3-nitro-1H-pyrazol-1-yl)propanoyl]-1-
piperazinecarboxylate 
- 
10 5.445 0.0257 475.2990 C33H37N3 
4-{Bis[4-(1-pyrrolidinyl)phenyl]methyl}-N,N-dimethyl-1-
naphthalenamine 
- 
11 5.628 0.9906 343.1051 C10H21N3O8S 
1-Azido-1-deoxy-2,3-bis-O-methoxymethyl)-5-O-
(methylsulfonyl)-D-ribitol 
- 
12 5.845 0.6908 550.0951 C24H22O15 Quercetin-3-(6''-malonyl)-Glucoside 
Antioxidant and 
antiatherogenic protective 
[26] 
13 6.177 1.0895 498.1166 C25H22O11 
4-(1,3-Benzodioxol-5-yl)-6-hydroxy-1-oxo 1,3-dihydronaphtho 
[2,3-c]furan-5-yl hexopyranoside 
- 
14 6.577 0.3205 534.1013 C24H22O14 
2(3,4Dihydroxyphenyl)-5-hydroxy-4-oxo-4H chromen-7-yl 6-O 
(carboxyacetyl)-β-Dglucopyranoside 
“luteolin 7-O-(6-O-malonyl-β-D-glucoside” 
- 
15 6.908 0.2713 219.1625 C14H21NO 1-[1-(4-Methoxyphenyl)cyclohexyl]methanamine - 
16 7.206 2.0878 196.1105 C11H16O3 1-carboxy-3-hydroxyadamantane - 
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17 7.423 0.8892 261.1731 C16H23NO2 
1-(7-Ethyl-1-benzofuran-2-yl)-2-[(2-methyl-2-
propanyl)amino]ethanol 
- 
18 7.903 0.3096 295.1565 C14H22N5Cl 
1-methyl-2-[(4-methylpiperazin-1-yl)methyl]benzimidaol-5-amine 
hydrochloride 
- 
19 8.406 1.4141 550.3668 C36H46N4O “Manzamine J” - 
20 8.886 0.0560 393.1997 C17H31NO9 
Ethyl (4S,5R,6R,7S,8R)-4,6,7,8,9pentahydroxy-2-methylene-5-
({[(2 methyl-2 propanyl) oxy]carbonyl}amino)nonanoate 
- 
21 9.321 0.1071 289.2038 C18H27NO2 1-(4-Butoxyphenyl)-3-(1-piperidinyl)-1-propanone (dyclonine) 
Inhibitor aldehyde 
dehydrogenase 1 [27],  
antimicroba [28] 
22 9.584 0.1649 323.1878 C13H29N3O4S 
(3R,4R)-3-{[(2-Hydroxyethyl)(methyl)amino]methyl}-4-
(hydroxymethyl)-N-isopropyl-N-methyl-1-pyrrolidinesulfonamide 
- 
23 10.601 0.6568 191.1315 C12H18NO N,N,N-Trimethyl-3-oxo-3-phenyl-1-propanaminium - 
24 10.830 0.3341 827.4180 C34H57N11O13 
L-α-Aspartyl-L-threonyl-3-(4H-imidazol-4-yl)-L-alanyl-L-lysyl-
L-seryl-L-α-glutamyl-L-isoleucinamide 
- 
25 11.082 0.4582 287.2817 Unknown Unknown - 
26 11.379 0.8714 665.3629 C36H51N5O5S 
(3R)-Tetrahydro-3-furanyl [(2S,3S,5S)-3-hydroxy-5-{[(2S)-2-{2-
[(2-isopropyl-1,3-thiazol-4-yl)methyl]-2-methylhydrazino}-3-
methylbutanoyl]amino}-1,6-diphenyl-2-hexanyl]carbamate 
- 
27 11.562 1.7782 310.1208 C14H19N4O2Cl Lintopride - 
28 11.928 0.4325 591.3256 C28H49NO12 
2-Methyl-2-propanyl 2-cyano-3-[(4S,5R)-5-{(5S,6R)-6-[(4R)-2,2-
dimethyl-1,3dioxolan-4-yl]-2,4,7,9-tetraoxadecan-5-yl}-2,2-
dimethyl-1,3-dioxolan-4-yl]-2-(1-ethoxyethoxy)propanoate 
- 
29 12.179 0.3815 467.3253 C27H49NOS2 
2-[(Bis{2-[(2-methyl-2propanyl)sulfanyl]ethyl}amino)methyl]-
4,6-bis(2-methyl-2-propanyl)phenol 
- 
30 12.397 1.5741 503.3094 C25H45NO9 Pederin Anticancer [29] 
31 12.614 1.9858 693.3938 C46H51N3O3 
2-{(2R)-2-[Benzoyl(methyl)amino]-2-phenylethyl}-6-{(2S)-2-
[benzoyl(methyl)amino]-2-phenylethyl}-N,N-diisopropyl-4-
methylbenzamide 
- 
32 12.797 2.5108 517.3168 C29H39N7O2 
1-(2-Methylalanyl-5-phenyl-D-norvalyl)-4-{2-[2-(2H-tetrazol-5-
yl)ethyl]phenyl}piperidine 
- 
33 13.208 0.9465 619.3571 C30H53NO12 
(3S)-16-{[(1S)-1-Carboxyethyl]amino}-2-methyl-16-oxo-3-
hexadecanyl 6-O-(3-carboxypropanoyl)-β-D-glucopyranoside 
- 
34 13.460 2.6423 495.3579 C29H45N5O2 
8-(Benzylamino)-7-hexadecyl-3-methyl-3,7-dihydro-1H-purine-
2,6-dione 
- 
35 13.677 2.4722 519.3339 C28H46N5O2Cl 
N4-(5-Chloro-2,4-dimethoxyphenyl)-N6-hexadecyl-4,5,6-
pyrimidinetriamine 
- 
36 14.409 10.3549 495.3331 C25H50NO6Cl Unknown - 
37 15.106 25.3622 746.3726 C22H48N9Cl 
N2-[3-({12-[(3-Aminopropyl)amino]dodecyl}amino)propyl]-N4-
methyl-1,3,5-triazine-2,4,6-triamine hydrochloride (1:1) 
- 
38 15.404 4.7166 499.3879 C24H50N9Cl Unknown - 
39 16.718 5.9510 701.2070 C36H36N5O6SCl 
4-[(N-{2-[(6-Chloro2-methyl-4-quinolinyl) amino]ethyl}-N-[(4-
methoxyphenyl)sulfonyl]-β-alanyl)amino]-3-methoxy-N-
phenylbenzamide 
- 
40 17.004 1,3681 553.1696 C7H24N19O9Cl Unknown - 
41 17.999 46577 849.2435 C46H48N5OS4Cl Unknown - 
42 18.330 13.6488 698.5885 C36H70N14 Unknown - 
 
 
 
Table 2 : Predicted compounds of 96% ethanol extract of M. crenata from Benowo 
District, Surabaya in DCM solvent 
No 
Rt 
(min) 
% Area 
Measured 
m/z 
Molecular 
Formula 
Proposed Metabolite Activity 
1 0.289 0.0032 278.1510 C11H23N4O2Cl 
2-Methyl-2-propanyl 4-carbamimidamido 1-
piperidinecarboxylate hydrochloride (1:1) 
- 
2 0.540 0.0278 278.1518 C16H22O4 Dibutyl phthalate 
Antibacterial [30], glycosidase 
inhibitors [31],  
estrogenic [32] 
3 0.906 0.0049 278.1526 C9H22N6O2S Unknown - 
4 1.969 0.0041 278.1503 C10H23N4O3P 
2[(Diisopropylphosphoryl)methyl]malonohydrazidePropan
edioic acid,2[[bis(1methylethyl)phosphinyl]methyl]-, 
dihydrazide 
- 
5 2.084 0.1072 201.1730 C11H23NO2 11-Aminoundecanoic Acid  
6 4.427 0.0282 301.1885 C15H27NO5 Megalanthonine Atifeedant and antifungal [33] 
7 4.930 0.0127 299.1935 C9H21N11O Unknown - 
8 5.342 0.2477 149.1205 C10H15N 4-Butylaniline - 
9 5.479 0.0731 431.2734 C18H41NO10 Unknown - 
10 5.662 0.0912 210.1261 C12H18O3 (2,4,6Trimethylbenzene1,3,5triyl)trimethanol - 
11 5.925 0.0405 519.3254 C35H41N3O 
N-Benzyl 2cycloheptyl-2-{4-[(4-methyl-5,6,7,8-
tetrahydro-9H-pyrido[2,3-b]indol-9-
yl)methyl]phenyl}acetamide 
- 
12 6.211 0.0164 563.3512 C37H45N3O2 
2,2'-{[2-Phenyl-2-
(2pyridinyl)1,1ethenediyl]bis(4,1phenyleneoxy)}bis(N,Ndi
ethylethanamine) 
- 
13 6.474 0.0109 607.3767 C23H49N11O8 Unknown - 
14 6.840 0.0041 122.0837 Unknown Unknown - 
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15 7.640 0.0242 215.1887 C12H25NO2 12-Aminododecanoic acid - 
16 8.006 0.1302 271.1935 C18H25NO Cyclazocine Hipnotic sedativa [34] 
17 9.504 0.0908 301.2406 C20H31NO Trihexyphenidyl 
Antiparkinson, antikolinergic 
[35], antioxidant [36] 
18 10.967 0.5387 191.1318 Unknown Unknown - 
19 11.448 2.3323 241.2775 C16H35N Hexadecylamine 
Antibacteri, adjuvant for 
diphtheria, tetanus toxoid,  
and influenza [37] 
20 11.630 0.3879 287.2827 C17H37NO2 2-Amino-2-tetradecyl-1,3-propanediol - 
21 12.111 0.0640 310.1781 C17H26O5 Portentol Anticancer [38] 
22 12.248 0.0123 227.2618 C15H33N Pentadecylamine - 
23 12.396 0.0027 315.3143 C19H41NO2 3-(Hexadecylamino)-1,2-propanediol - 
24 12.694 0.7068 310.1202 C19H18O4 Benzylbutylphthalat Estrogenic [32] 
25 12.842 0.9778 303.2928 C21H37N 4-Pentadecylaniline - 
26 13.894 0.9962 331.3237 C23H41N N-Benzyl-N-octyl-1-octanamine - 
27 15.072 23.3154 627.1879 C12H21N25O5S Unknown - 
28 15.987 26.3455 775.2257 C38H38N5O11Cl 
(1R,13S,16S,17R,28)-28-Amino-20-chloro-
17,25dihydroxy5,8,10,24tetramethoxyNmethyl-
15,29,31trioxo-
22oxa14,30,32triazahexacyclo[14.14.2.218,21.12,6.123,27
.07,12]hexatriaconta-2(36),3,5 
,7,9,11,18,20,23(33),24,26,34-dodecaene-13-carboxamide 
- 
29 17.050 0.4132 923.2661 C41H35N21O2Cl2 Unknown - 
30 17.599 1.9907 592.2688 C35H36N4O5 Pheophorbide A Anticancer [39] 
31 18.433 37.6384 701.2070 C36H36N5O6SCl 
4[(N{2[(6Chloro2methyl4quinolinyl)amino]ethyl}N[(4met
hoxyphenyl)sulfonyl]βalanyl)amino]-3-methoxy-N-
phenylbenzamide 
- 
32 21.658 0.0399 156.9953 C12N Unknown - 
33 22.572 2.8467 278.1517 C7H10N2 2-Pyridylethylamine Histamine agonist [40] 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Docking Result : (A) Ligand position after docking (green) in redocking process, 
(B) interaction between predicted compound (green) and original ligand (yellow) 
with amino acids in ER-β 
 
 
 
Table 3. Compounds from 96% ethanol extract of M. crenata leaves which act as ER-β 
agonist 
No. Compound Code Compounds 
Binding 
Affinity 
TPSA % Area 
Amino Acid 
Interaction 
1 MTL7 Prochlorperazine -4.9 35.02 0.1836 
Glu305, His475 
 
2 MTL17 
1-methyl-2-[(4-methylpiperazin-1-
yl)methyl]benzimidaol-5-amine 
hydrochloride 
-5.8 50.32 0.3096 
Glu305, His475 
 
3 DCM10 12-Aminododecanoic acid -5.6 63.32 0.0246 
Glu305, His475 
 
Control - 
17β-estradi 
ol 
- 10.5 - - 
Glu305, His475, 
Arg 46 
 
A B 
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Table 3. Compounds from 96% ethanol extract of M. crenata leaves which act as ER-β 
antagonis 
No. Compound Code Compounds 
Binding 
Affinity 
TPSA % Area 
Amino Acid 
Interaction 
1 DCM24 2-Pyridylethylamine -4.5 38.91 2.8467 Glu305 
2 DCM4 11-Aminoundecanoic acid -6.6 63.32 0.1072 Glu305 
3 MTL6 3-Hydroxy-2H-chromen-2-one -6.5 50.44 0.3629 Glu305 
4 DCM11 Cyclazocine -7.5 23.47 0.1302 Glu305 
5 DCM14 2-Amino-2-tetradecyl-1,3-propanediol -6.1 66.48 0.3879 Glu305 
6 DCM16 Pentadecylamine -6 26.02 0.0123 Glu305 
 
 
 
Figure 3. Boiled-Egg diagram of three compounds from 96% ethanol extract of M. crenata 
leaves which act as ER-β agonist : Molecule 1 : 17β estradiol; Molecule 2 : Prochlorperazine; 
Molecule 3 : 1-methyl-2-[(4-methylpiperazin-1-yl) methyl] benzimidaol-5-amine 
 
 
 
From the Boiled-Egg diagram in 
Figure 3, it can be observed that the three 
compounds which act as ER-β agonist and 
17β-estradiol as positif control are in the 
yellow region, which indicates that these 
compounds can penetrate the BBB and can 
work on ER-β. In the diagram, all 
compounds except DCM10 (12-
aminododecanoic acid) has a blue colour 
indicating that it can bind to the P-gp 
substrate in the brain, which causes the 
compound to have a short duration of 
action and easily excreted from the body 
[17]. While the DCM10 did not show any 
bond with the P-gp substrate, so it could 
work with longer duration in the brain [40]. 
ER-β is present in several types of 
cells in the brain, one of them is microglia 
cells. Microglia cells are responsible for 
the neuroinflamation process which is one 
of the main neurodegenerative causes [11]. 
In neuroinflamation, an increase in the 
immune system response characterized by 
an increase in the number of microglia cells 
activated in M1 polarity pathway due to 
estrogen deficiency, causes an increase in 
inflammatory cytokines such as 
interleukin-1 (IL-1), interleukin-6 (IL-6), 
tumor necrosis factor-α (TNF-α), and nitric 
oxide (NO) in the brain [41]. This event 
will reduce synaptic function and neuronal 
plasticity, and induce neuronal cell 
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apoptosis [11, 41]. Even so, further 
research is still needed to ascertain the 
activity of compounds in 96% ethanol 
extract of M. crenata leaves as anti-
neuroinflammatory. 
 
CONCLUSIONS 
From UPLC-QToF-MS/MS 
analysis, There were 75 compounds 
contained in 96% ethanol extract of M. 
crenata leaves, either detected compounds 
(59 compounds), or unknown compounds. 
The molecular docking simulation shows 
there are 3 compounds that are predicted to 
have activities similar to 17β-estradiol as 
anti-neuroinflammatory, they are 
prochlorperazine, 12-Aminododecanoic 
acid, and 1-methyl-2-[(4-methylpiperazin-
1-yl)methyl]benzimidaol-5-amine 
hydrochloride. 
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